Kupffer cells

Kupffer cells are the resident macrophages of the liver, located along the walls of hepatic sinusoids, particularly concentrated in periportal areas where blood first enters from the portal vein and hepatic artery. They arise from yolk-sac progenitors during embryogenesis and are maintained by local proliferation, with additional contribution from circulating monocytes under inflammatory conditions.

Functionally, Kupffer cells serve as a first line of defense against gut-derived bacteria, endotoxins (LPS), and particulate matter absorbed from the portal circulation, given the liver's unique exposure to gut-derived antigens via the portal vein. They phagocytose senescent red blood cells, releasing heme, which is metabolized to bilirubin (relevant to bilirubin metabolism and jaundice pathways) and recycling iron via ferritin and transferrin pathways.

Clinically, Kupffer cells are implicated in the pathogenesis of several liver diseases: - In alcoholic liver disease and NASH, Kupffer cell activation by LPS via TLR4 leads to release of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta), contributing to hepatocyte injury, inflammation, and fibrosis. - In viral hepatitis, Kupffer cells contribute to antigen presentation and immune-mediated hepatocyte damage. - They are also involved in clearing bacteria in sepsis and are a site of granuloma formation in diseases like schistosomiasis and tuberculosis. - Kupffer cell hyperplasia/hypertrophy can be seen histologically in various hepatic insults. - They express Fc and complement receptors, aiding in immune complex clearance.

Histologically, Kupffer cells can be identified using CD68, CD163, or F4/80 (in mice) markers. They are distinct from hepatic stellate cells (which store vitamin A and become activated to produce collagen in fibrosis) and sinusoidal endothelial cells, though these cell types interact closely in liver injury and repair.

High-yield associations for boards: reticuloendothelial system component, phagocytosis of senescent RBCs, LPS/TLR4-mediated activation in alcoholic and metabolic liver disease, source of TNF-alpha contributing to hepatocyte apoptosis and fibrosis, and role in systemic clearance of bacteria and endotoxin from portal circulation.